- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/675 - Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
Patent holdings for IPC class A61K 31/675
Total number of patents in this class: 4610
10-year publication summary
|
341
|
361
|
379
|
379
|
375
|
494
|
490
|
455
|
421
|
195
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 2028 |
124 |
| Antecip Bioventures II LLC | 328 |
101 |
| Iovance Biotherapeutics, Inc. | 338 |
67 |
| Merck Sharp & Dohme LLC | 3741 |
46 |
| Immunomedics, Inc. | 267 |
42 |
| The Regents of the University of California | 19812 |
39 |
| The Johns Hopkins University | 5642 |
37 |
| Novartis AG | 10904 |
36 |
| Bristol-myers Squibb Company | 4892 |
36 |
| Rigel Pharmaceuticals, Inc. | 540 |
35 |
| Psilo Scientific Ltd. | 54 |
35 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2837 |
27 |
| Achillion Pharmaceuticals, Inc. | 164 |
23 |
| Cipla Limited | 467 |
23 |
| Centre National de La Recherche Scientifique | 10321 |
21 |
| Turtle Bear Holdings, LLC | 88 |
20 |
| Allergan, Inc. | 2362 |
19 |
| Pharmacyclics LLC | 238 |
18 |
| Ascentage Pharma (Suzhou) Co., Ltd. | 174 |
18 |
| Hoffmann-La Roche Inc. | 3379 |
17 |
| Other owners | 3826 |